About Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Clinical Trials at Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed
During the past decade, Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed
According to Clinical.Site data, the most researched conditions in "Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed" are
"Acute Respiratory Distress Syndrome" (1 trials), "Atrial Fibrillation" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed" in a lesser frequency.
Clinical Trials Intervention Types at Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed
Most popular intervention types in "Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "BAY1211163" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed
The vast majority of trials in "Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed" are
2 trials for "All" genders.
Clinical Trials Status at Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed
Currently, there are NaN active trials in "Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sana-Klinikum Remscheid|Kardio, Angio, Pneumo u. Intensivmed, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".